Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fentanyl actavis forðaplástur 50 míkróg/klst.
actavis group ptc ehf. - fentanylum inn - forðaplástur - 50 míkróg/klst.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fentanyl actavis forðaplástur 75 míkróg/klst.
actavis group ptc ehf. - fentanylum inn - forðaplástur - 75 míkróg/klst.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fentanyl alvogen (fentanyl ratopharm) forðaplástur 12 míkróg/klst.
alvogen ehf. - fentanylum inn - forðaplástur - 12 míkróg/klst.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
fentanyl alvogen (fentanyl ratiopharm) forðaplástur 50 míkróg/klst.
alvogen ehf. - fentanylum inn - forðaplástur - 50 míkróg/klst.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
zassida stungulyfsstofn, dreifa 25 mg/ml
zentiva k.s.* - azacitidinum inn - stungulyfsstofn, dreifa - 25 mg/ml
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - Öll önnur lækningavörur - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - taugakerfi - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
sugammadex hameln stungulyf, lausn 100 mg/ml
hameln pharma gmbh - sugammadex sodium - stungulyf, lausn - 100 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
azacitidine zentiva stungulyfsstofn, dreifa 25 mg/ml
zentiva k.s.* - stungulyfsstofn, dreifa - 25 mg/ml
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
artesunate amivas
amivas ireland ltd - artesunate - malaría - krabbamein - artesunate amivas is indicated for the initial treatment of severe malaria in adults and children. Íhuga ætti að opinbera leiðsögn á réttri notkun malaríulyf lyfjum.